title: Plasma glucose regulation and insulin secretion in hypertriglyceridemic mice.
abstract: In this study, we examined glucose homeostasis and insulin secretion in transgenic mice overexpressing the human apolipoprotein CIII gene (apo CIII tg). These mice have elevated plasma levels of triglycerides, FFA and cholesterol compared to control mice. The body weight, plasma glucose, and insulin levels, glucose disappearance rates, areas under the ipGTT curve for adult (4 - 8 mo. old) and aged (20 - 24 mo. old) apo CIII tg mice and the determination of insulin during the ipGTT were not different from those of control mice. However, an additional elevation of plasma FFA by treatment with heparin for 2 - 4 h impaired the ipGTT responses in apo CIII tg mice compared to saline-treated mice. The glucose disappearance rate in heparin-treated transgenic mice was slightly lower than in heparin-treated controls. Glucose (22.2 mmol/l) stimulated insulin secretion in isolated islets to the same extent in saline-treated control and apo CIII tg mice. In islets from heparin-treated apo CIII tg mice, the insulin secretion at 2.8 and 22.2 mmol glucose/l was lower than in heparin-treated control mice. In conclusion, hypertriglyceridemia per se or a mild elevation in FFA did not affect insulin secretion or insulin resistance in adult or aged apo CIII tg mice. Nonetheless, an additional elevation of FFA induced by heparin in hypertriglyceridemic mice impaired the ipGTT by reducing insulin secretion.
authors.affiliation: Departamento de Fisiologia e Biofísica, Instituto de Biologia, Universidade Estadual de Campinas (UNICAMP), CP 6109 Campinas, SP, 13083-970 Brazil.
authors.forename: M E C
authors.initials: ME
authors.lastname: Amaral
authors.forename: H C F
authors.initials: HC
authors.lastname: Oliveira
authors.forename: E M
authors.initials: EM
authors.lastname: Carneiro
authors.forename: V
authors.initials: V
authors.lastname: Delghingaro-Augusto
authors.forename: E C
authors.initials: EC
authors.lastname: Vieira
authors.forename: J A
authors.initials: JA
authors.lastname: Berti
authors.forename: A C
authors.initials: AC
authors.lastname: Boschero
mesh_terms: D000818:Animals; D053305:Apolipoprotein C-III; D001056:Apolipoproteins C / Q000502:physiology; D019540:Area Under Curve; D001786:Blood Glucose / Q000378:metabolism*; D001835:Body Weight; D002784:Cholesterol / Q000097:blood; D005230:Fatty Acids, Nonesterified; D005260:Female; D005951:Glucose Tolerance Test; D006493:Heparin / Q000008:administration & dosage; D015228:Hypertriglyceridemia / Q000097:blood* / Q000503:physiopathology; D007328:Insulin / Q000097:blood / Q000378:metabolism* / Q000502:physiology; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000378:metabolism*; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D018709:Statistics, Nonparametric; D014280:Triglycerides / Q000097:blood
chemical_list: D053305:Apolipoprotein C-III; D001056:Apolipoproteins C; D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D014280:Triglycerides; D006493:Heparin; D002784:Cholesterol